Correlation Between Anixa Biosciences and Armata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Anixa Biosciences and Armata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anixa Biosciences and Armata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anixa Biosciences and Armata Pharmaceuticals, you can compare the effects of market volatilities on Anixa Biosciences and Armata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anixa Biosciences with a short position of Armata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anixa Biosciences and Armata Pharmaceuticals.
Diversification Opportunities for Anixa Biosciences and Armata Pharmaceuticals
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Anixa and Armata is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Anixa Biosciences and Armata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Armata Pharmaceuticals and Anixa Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anixa Biosciences are associated (or correlated) with Armata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Armata Pharmaceuticals has no effect on the direction of Anixa Biosciences i.e., Anixa Biosciences and Armata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Anixa Biosciences and Armata Pharmaceuticals
Given the investment horizon of 90 days Anixa Biosciences is expected to under-perform the Armata Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Anixa Biosciences is 1.88 times less risky than Armata Pharmaceuticals. The stock trades about -0.25 of its potential returns per unit of risk. The Armata Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 232.00 in Armata Pharmaceuticals on August 28, 2024 and sell it today you would lose (3.00) from holding Armata Pharmaceuticals or give up 1.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Anixa Biosciences vs. Armata Pharmaceuticals
Performance |
| Timeline |
| Anixa Biosciences |
| Armata Pharmaceuticals |
Anixa Biosciences and Armata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anixa Biosciences and Armata Pharmaceuticals
The main advantage of trading using opposite Anixa Biosciences and Armata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anixa Biosciences position performs unexpectedly, Armata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Armata Pharmaceuticals will offset losses from the drop in Armata Pharmaceuticals' long position.| Anixa Biosciences vs. Eliem Therapeutics | Anixa Biosciences vs. HCW Biologics | Anixa Biosciences vs. Scpharmaceuticals | Anixa Biosciences vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |